Comorbidities of Epilepsy

Epilepsy Clinical Trial

Official title:

Comorbidities of Epilepsy

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT04106284
• Other study ID #: Comorbidities of epilepsy
• Status: Not yet recruiting
• Start date: October 1, 2019
• Est. completion date: December 1, 2020

Study information

• Verified date: September 2019
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Epilepsy is the second commonest chronic neurological disorder in developed countries, Comorbidity refers to the co-occurrence of two conditions with a greater frequency than found in the general population

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 100
• Est. completion date: December 1, 2020
• Est. primary completion date: October 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients diagnosed as primary epilepsy either newly diagnosed or on AEDs

• Aged above 18 years old

• Males and females

Exclusion Criteria:

• Patients diagnosed as secondary epilepsy (post stroke, trauma, tumor, encephalitis, etc).

• Patients diagnosed as epilepsy syndrome

Related Conditions & MeSH terms

• Epilepsy

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	DEXA Scan	DEXA scan to measure bone mineral density at 3 points (wrist joint ,hip joint and lumbo-sacral vertebrae)	1 year